Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents

Hepatitis C virus (HCV) genotype 3 is responsible for 30.1% of chronic hepatitis C infection cases worldwide. In the era of direct-acting antivirals, these patients have become one of the most challenging to treat, due to fewer effective drug options, higher risk of developing cirrhosis and hepatoce...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Braz J Med Biol Res
Main Authors: Zanaga, L.P., Miotto, N., Mendes, L.C., Stucchi, R.S.B., Vigani, A.G.
Format: Artigo
Sprog:Inglês
Udgivet: Associação Brasileira de Divulgação Científica 2016
Fag:
Reviews
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5089232/
https://ncbi.nlm.nih.gov/pubmed/27783808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/1414-431X20165504
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker